What is the market price of ibrutinib in 2025?

Ibrutinib (Ibrutinib), as an inhibitor targeting Bruton's tyrosine kinase (BTK), is widely used to treat malignant tumors such as mantle cell lymphoma and chronic lymphocytic leukemia (CLL). Since its launch, ibrutinib has become a standard treatment for a variety of BB cell-related diseases. However, the affordability of this drug has been a concern due to its high market pricing.

In China, ibrutinib has been successfully included in the medical insurance catalog and is partially reimbursed for eligible patients. In China, the price of ibrutinib is approximately 8,000 yuan, and the specific price will fluctuate depending on the region and pharmacy. Due to the coverage of medical insurance, patients can reduce the burden of drug costs to a certain extent through medical insurance reimbursement. However, the specific amount and policy of medical insurance reimbursement may vary by region and hospital. Patients need to consult the local hospital pharmacy to understand the accurate reimbursement ratio and personal out-of-pocket portion.

In overseas markets, the price of ibrutinib varies greatly. In some regions, especially in some generic drug-producing countries, the price of generic versions of ibrutinib is significantly lower than that of the original drug. For example, the price of generic versions of ibrutinib, such as 140mg*120 capsules and 140mg*112 capsules, is usually more affordable, around 1,000 RMB. This makes it more affordable for patients, especially in developing countries, where the popularity of generic drugs has greatly reduced the cost of treatment.

However, despite the existence of generic versions on the market, generic drug prices are still higher in some countries. For example, the generic version of ibrutinib produced by Bicon of Bangladesh is priced close to 4,000 yuan, which is much higher than the price of other generic versions. This price level is still cheaper than the original drug, but compared to other generic drugs, it is still a more expensive option.

Reference materials:https://www.imbruvica.com/